Gian Life Care Limited (BOM:542918)
India · Delayed Price · Currency is INR 9.39
-0.08 (-0.84%)
At close: Feb 13, 2026
Gian Life Care Revenue
Gian Life Care had revenue of 6.60M INR in the quarter ending September 30, 2025, a decrease of -66.09%. This brings the company's revenue in the last twelve months to 42.29M, down -65.68% year-over-year. In the fiscal year ending March 31, 2025, Gian Life Care had annual revenue of 66.31M, down -49.46%.
Revenue (ttm)
42.29M
Revenue Growth
-65.68%
P/S Ratio
2.30
Revenue / Employee
1.76M
Employees
24
Market Cap
97.11M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 66.31M | -64.89M | -49.46% |
| Mar 31, 2024 | 131.20M | 11.95M | 10.02% |
| Mar 31, 2023 | 119.25M | -40.05M | -25.14% |
| Mar 31, 2022 | 159.30M | 54.75M | 52.37% |
| Mar 31, 2021 | 104.55M | 28.10M | 36.75% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Thyrocare Technologies | 7.92B |
| One Global Service Provider | 3.37B |
| Chandan Healthcare | 2.57B |
| Star Imaging and Path Lab | 860.99M |
| Modern Diagnostic & Research Centre | 814.48M |
| Invicta Diagnostic | 301.81M |
| Nidan Laboratories and Healthcare | 271.16M |
| Aspira Pathlab & Diagnostics | 242.36M |